Elyse E. Lower

The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP)

ERS clinical practice guidelines on treatment of sarcoidosis

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis

Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry

Advances in Therapeutic Approaches for Triple-Negative Breast Cancer

When the Game Changes

Evaluating the Minimal Clinically Important Difference of the King’s Sarcoidosis Questionnaire in a Multicenter Prospective Study

Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire.

Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry

Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)

Repository corticotropin for Chronic Pulmonary Sarcoidosis

A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients

Rituximab in the treatment of refractory pulmonary sarcoidosis